Translate

Monday, September 13, 2021

thumbnail

SBPH Spring Bank Pharmaceuticals Inc gains 29% Sep 10, 2021

Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapeutics using its proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. Its SMNH compounds are small segments of nucleic acids that are design to target and modulate the activity of specific proteins implicated in various disease states. The company's lead product candidate is SB 9200, which completed a Phase 1 clinical trial for the treatment of chronic hepatitis B virus and respiratory syncytial virus. It also develops SMNH product candidate, SB 11285, an immunotherapeutic agent for the treatment of selected cancers; and SB 9400, SB 9941 and SB 9946 preclinical product candidates for viral diseases. The company has an agreement with Arrowhead Pharmaceuticals, Inc. to collaborate on the study of the combined use of SB 9200 and small interfering ribonucleic acid product pipeline for the treatment of chronic hepatitis B virus (HBV); and Arbutus Biopharma Corporation to collaborate on the preclinical study of the combined use of SB 9200 and AB-423, a capsid assembly inhibitor for the treatment of chronic HBV. The company was formerly known as Spring Bank Technologies, Inc. and changed its name to Spring Bank Pharmaceuticals, Inc. in May 2008. Spring Bank Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Hopkinton, Massachusetts.http://www.priceseries.com/trade/SBPH-Spring-Bank-Pharmaceuticals-Inc-stock-gains-29-percent-a-Trade-Record-by-priceSeries-2021082020210910.html
thumbnail

PRFT Perficient, Inc. gains 37% Sep 13, 2021

Perficient, Inc. provides digital consultancy services and solutions in the United States. Its solutions include portals and collaboration, such as searchable data systems, collaborative systems for process improvement, transaction processing, unified and extended reporting, commerce, content management, and other services; and platform implementation services, including application server selection, architecture planning, installation and configuration, clustering for availability, performance assessment and issue remediation, security, and technology migrations. The company also offers management consulting services in the areas of organizational change management, business analytics, project management, and process excellence; and cloud infrastructure services comprising architecture, application modernization, business value and health checks assessments, containers, strategy and road maps, and vendor evaluation and selection services. In addition, it provides digital marketing services, including analytics and reporting, email marketing and automation, B2B and B2C marketing automation, media and advertising, paid search, social media, search engine marketing, content marketing, and conversion rate optimization. Further, the company offers business analytics; custom applications; business integration; business process management; customer relationship management; enterprise data and business intelligence; enterprise performance management; DevOps; and enterprise mobile solutions. It serves the healthcare, financial services, manufacturing, automotive and transportation, retail and consumer goods, electronics and computer hardware, telecommunications, business services, and energy and utilities markets, as well as leisure, media, and entertainment markets. Perficient, Inc. was founded in 1997 and is headquartered in St. Louis, Missouri.http://www.priceseries.com/trade/PRFT-Perficient-Inc-stock-gains-37-percent-a-Trade-Record-by-priceSeries-2021072620210913.html
thumbnail

LXRX Lexicon Pharmaceuticals, Inc. gains 19% Sep 13, 2021

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of pharmaceutical products. The company offers XERMELO, an orally-delivered small molecule drug candidate for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog therapy in adults. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the treatment of type 1 and is in Phase III clinical trials for the treatment of type 2 diabetes; LX9211, which is in Phase I clinical development for the treatment of neuropathic pain; and LX2761 that is in Phase I clinical development for the treatment of diabetes. The company has strategic collaboration and license agreements with Ipsen Pharma SAS; Bristol-Myers Squibb Company; and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was founded in 1995 and is headquartered in The Woodlands, Texas.http://www.priceseries.com/trade/LXRX-Lexicon-Pharmaceuticals-Inc-stock-gains-19-percent-a-Trade-Record-by-priceSeries-2021082320210913.html
thumbnail

LTRX Lantronix, Inc. gains 22% Sep 13, 2021

Lantronix, Inc. provides secure data access and management solutions for Internet of Things (IoT) and information technology (IT) assets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific Japan. Its IoT products include IoT gateways, which provide secure connectivity and the ability to add integrated device management and advanced data access features; and IoT building blocks that offer basic secure machine connectivity and unmanaged data access. The company also offers IT management products, which comprise console management, power management, and keyboard video mouse products that offer remote out-of-band management access to IT and networking infrastructure deployed in test labs, data centers, and server rooms, as well as other products. Lantronix, Inc. provides its IT management and device IoT solutions through value added resellers, systems integrators, distributors, consumers, corporate customers, and government entities, e-tailers, original design manufacturers, and original equipment manufacturers. The company was founded in 1989 and is headquartered in Irvine, California.http://www.priceseries.com/trade/LTRX-Lantronix-Inc-stock-gains-22-percent-a-Trade-Record-by-priceSeries-2021082420210913.html
thumbnail

IT Gartner, Inc. gains 20% Sep 13, 2021

Gartner, Inc. operates as a research and advisory company in the United States, Canada, Europe, the Middle East, Africa, and internationally. It operates through three segments: Research, Conferences, and Consulting. The Research segment offers objective insights and advice on the priorities of various leaders in a range of functional areas of the enterprise through reports, briefings, proprietary tools, access to research expert, peer networking services, and membership programs that enable clients to drive organizational performance. This segment delivers its research primarily through a subscription service. The Conferences segment offers business professionals in an organization the opportunity to learn, share, and network. The Consulting segment offers market research, custom analysis, and on-the-ground support services. This segment also offers actionable solutions for IT-related priorities, including IT cost optimization, digital transformation, and IT sourcing optimization. Gartner, Inc. was founded in 1979 and is headquartered in Stamford, Connecticut.http://www.priceseries.com/trade/IT-Gartner-Inc-stock-gains-20-percent-a-Trade-Record-by-priceSeries-2021072120210913.html
thumbnail

GLOB Globant S.A. gains 31% Sep 13, 2021

Globant S.A. operates as a technology services company worldwide. The company offers machine learning, pattern recognition, and natural language understanding services. It also provides process appraisal, automated, process evolution, delivery management, agile consultancy, management consulting, user experience, visual and service design, industrial design, consultancy, fast prototyping, app evolution, platform integration, and hardware integration services. In addition, the company offers game engineering and experience, digital platform, virtual and augmented reality, graphics engineering, 3D and 2D art, e-Sports, data architecture, data science, mission critical, data integration, data visualization, and blockchain services. Further, it provides Internet of Things experience and consultancy, platform, hardware integration, content management system, digital marketing, OTT, and Cloud Ops Studio services. Additionally, the company offers functional testing, load and performance testing, mobile testing, test automation, Web applications, hybrid and cross-compiled development, accessibility, API management, micro, complex architecture, software archaeology, IT service management, and software evolution services, as well as services over platforms. It also provides biological and technological solutions to healthcare, agriculture, and pharmaceutical organizations. The company serves medium-to large-sized companies operating in media and entertainment, professional services, technology and telecommunications, travel and hospitality, banks, financial services and insurance, consumer, retail, and manufacturing industries. The company was formerly known as IT Outsourcing S.L. and changed its name to Globant S.A. in December 2012. Globant S.A. was founded in 2003 and is based in Luxembourg City, Luxembourg.http://www.priceseries.com/trade/GLOB-Globant-SA-stock-gains-31-percent-a-Trade-Record-by-priceSeries-2021080420210913.html
thumbnail

BFR BBVA Banco Frances S.A. gains 27% Sep 10, 2021

BBVA Banco Frances S.A., together with its subsidiaries, provides various financial services to corporations, medium and small companies, and individual customers in Spain, Mexico, South America, the United States, and Eurasia. The company offers checking and savings accounts, time deposits, and trading and investment accounts. It also provides loans to the public sector, loans to local financial institutions, and short-term loans to companies, as well as overdraft lines of credit, discounted instruments, real estate mortgage loans, collateral loans, consumer loans, credit card loans, and short-term placements in foreign banks. In addition, the company offers fire, household, civil liability, theft, personal accidents, group life, and other insurance coverage products; payroll management services; investment fund and pension management services; stock exchange brokerage; and insurance advisory services to customers in the areas of coverage of risks related to life, personal accidents, as well as home and automatic teller machines (ATMs) robbery insurance. Further, it provides portfolio and asset management; foreign trade services, including letters of credit, collections, bank drafts, fund transfers, and foreign currency transactions; and electronic banking and trust services, as well as issues and trades in commercial papers, corporate bonds, trust bonds, other credit instruments, and futures and options. As of December 31, 2015, it operated through a network of 285 attention-to-clients units; 14 in-company branches; 1 points of sale; and other distribution channels, such as 694 ATMs, 797 self-service terminals, a telephone banking, and an Internet banking service. The company was formerly known as Banco Frances S.A. and changed its name to BBVA Banco Frances S.A. in October 2000. The company was founded in 1886 and is headquartered in Buenos Aires, the Republic of Argentina.http://www.priceseries.com/trade/BFR-BBVA-Banco-Frances-SA-stock-gains-27-percent-a-Trade-Record-by-priceSeries-2021082020210910.html
thumbnail

A Agilent Technologies, Inc. gains 15% Sep 13, 2021

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid and gas chromatography systems and components; liquid and gas chromatography mass spectrometry systems; inductively coupled plasma mass and optical emission spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate readers; laboratory software, information management, and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment, genetic data management, and interpretation support software; and equipment to produce synthesized oligonucleotide. It also offers immunohistochemistry, in situ hybridization, and hematoxylin and eosin staining and special staining; instruments, consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. It has collaboration agreement with SGS AXYS. The company was incorporated in 1999 and is headquartered in Santa Clara, California.http://www.priceseries.com/trade/A-Agilent-Technologies-Inc-stock-gains-15-percent-a-Trade-Record-by-priceSeries-2021072820210913.html

Friday, September 10, 2021

thumbnail

VRNS Varonis Systems, Inc. gains 17% Sep 10, 2021

Varonis Systems, Inc. provides software products and services that allow enterprises to manage, analyze, and secure enterprise data in North America, Europe, the Middle East, Africa, and internationally. Its software enables enterprises to protect data stored on premises and in the cloud, including sensitive files and emails; confidential personal data belonging to customers, and patients and employees' data; financial records; strategic and product plans; and other intellectual property. The company offers DatAdvantage that captures, aggregates, normalizes, and analyzes every data access event for users on Windows and UNIX/Linux servers, storage devices, email systems, and Intranet servers; and DatAlert that profiles users and their behaviors related to systems and data, detects and alerts on deviations that indicate compromise, and provides a Web-based dashboard and investigative interface. It also provides Data Classification Engine that identifies and tags data based on criteria set in various metadata dimensions, and provides business and information technology (IT) personnel with actionable intelligence about data; and DataPrivilege, which provides a self-service Web portal that allows users to request access to data necessary for their business functions, and owners to grant access without IT intervention. In addition, the company offers Data Transport Engine, which provides an execution engine that unifies the manipulation of data and metadata, translating business decisions, and instructions into technical commands, such as data migration or archiving; and DatAnswers that offers search functionality for enterprise data. It sells its products and services through a network of distributors and resellers. The company serves IT, security, and business personnel. Varonis Systems, Inc. was incorporated in 2004 and is headquartered in New York, New York.http://www.priceseries.com/trade/VRNS-Varonis-Systems-Inc-stock-gains-17-percent-a-Trade-Record-by-priceSeries-2021082320210910.html
thumbnail

VCYT Veracyte, Inc. gains 21% Sep 10, 2021

Veracyte, Inc. operates as a genomic diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to identify patients with benign thyroid nodules among those with indeterminate cytopathology results in order to rule out unnecessary thyroid surgery; Percepta Genomic Sequencing Classifier for lung cancer diagnosis; Envisia Genomic Classifier that help physicians to differentiate idiopathic pulmonary fibrosis from other interstitial lung diseases without the need for surgery; and Prosigna Breast Cancer Prognostic Gene Signature Assay test that informs next steps for patients with early-stage breast cancer, as well as provides cancer subtype classification information. It is also developing nasal swab test for early lung cancer detection; Percepta Genomic Atlas for genomic profiling information on small samples of the tumor biopsy; Envisia Classifier, the nCounter analysis system; and LymphMark for lymphoma subtyping test. Veracyte, Inc. has biopharmaceutical collaborations with Johnson & Johnson; Acerta Pharma; Loxo Oncology, Inc.; and Bayer AG. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.http://www.priceseries.com/trade/VCYT-Veracyte-Inc-stock-gains-21-percent-a-Trade-Record-by-priceSeries-2021082320210910.html

TradeVisor Product Review

Review I II III IV

Blog Archive